首页> 外文OA文献 >A Formal Toxicology Study of the Safety, Tolerability, and Efficacy of Gene-Pulmonary Macrophage Transplantation (PMT) Therapy of Hereditary Pulmonary Alveolar Proteinosis (HPAP)

【2h】

A Formal Toxicology Study of the Safety, Tolerability, and Efficacy of Gene-Pulmonary Macrophage Transplantation (PMT) Therapy of Hereditary Pulmonary Alveolar Proteinosis (HPAP)

机译：基因 - 肺巨噬细胞移植（PMT）治疗遗传性肺肺泡蛋白症（HPAP）的安全性，耐受性和疗效的正式毒理学研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
P.I. Arumugam; K. Shima; M. Wessendarp; Y. Ma; B.C. Carey; D.J.K. Yombo; M. Collins; M. Imbrogno; D. Black; C. Chalk; N. Lachmann; T. Moritz; T. Suzuki; B.C. Trapnell;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pulmonary macrophage transplantation therapy in Csf2ra gene-deficient mice, a novel clinically relevant model of children with hereditary pulmonary alveolar proteinosis [J] . Suzuki Takuji, Shima Kenjiro, Arumugam Paritha, Cytokine . 2017,第期

机译：CSF2RA基因缺乏小鼠肺部巨噬细胞移植治疗，一种新型临床相关模型的遗传性肺肺泡蛋白症
2. Long-Term Safety and Efficacy of Gene-Pulmonary Macrophage Transplantation Therapy of PAP in Csf2ra ?/? Mice [J] . Paritha Arumugam, Takuji Suzuki, Kenjiro Shima, Molecular therapy: the journal of the American Society of Gene Therapy . 2019,第9期

机译：CSF2RA中PAP基因 - 肺巨噬细胞移植治疗的长期安全性和疗效？/？老鼠
3. Pulmonary Macrophage Transplantation Therapy ofHereditary Pulmonary Alveolar Proteinosis [J] . Takuji Suzuki The Keio Journal of Medicine . 2015,第3期

机译：遗传性肺泡蛋白沉着症的肺巨噬细胞移植治疗
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. Conditional Disruption of Hem-1 Results in Impaired Development of Alveolar Macrophages, Pulmonary Alveolar Proteinosis, and Increased Susceptibility to Influenza Virus Infection [D] . Suwankitwat, Nutthakarn . 2019

机译：条件破坏HEM-1导致肺泡巨噬细胞，肺肺泡蛋白病的发育受损，对流感病毒感染的易感性增加
6. Long-Term Safety and Efficacy of Gene-Pulmonary Macrophage Transplantation Therapy of PAP in Csf2ra−/− Mice [O] . Paritha Arumugam, Takuji Suzuki, Kenjiro Shima, 2019

机译：CSF2RA / - 小鼠PAP基因 - 肺巨噬细胞移植治疗的长期安全性和疗效
7. 35. Establishment of the Dose-Response Relationship Needed for Human Translation of Pulmonary Macrophage Transplantation (PMT) Therapy of Hereditary Pulmonary Alveolar Proteinosis (hPAP) [O] . Paritha I. Arumugam, Takuji Suzuki, Anthony Sallese, 2016

机译：35.建立人类翻译肺部巨噬细胞移植（PMT）治疗遗传性肺肺泡蛋白病（HPAP）所需的剂量 - 反应关系

A Formal Toxicology Study of the Safety, Tolerability, and Efficacy of Gene-Pulmonary Macrophage Transplantation (PMT) Therapy of Hereditary Pulmonary Alveolar Proteinosis (HPAP)

著录项

引文网络

相似文献

相关主题

期刊订阅